Acute granulocytic leukemia type m2a is a type of acute granulocytic leukemia, a clonal malignant disease of hematopoietic stem cells. 1.Acute leukemia is distinguished by the degree of leukocyte development and maturation, and can be divided into acute and chronic leukemia. Acute leukemia is distinguished by different types of leukocytes, which can be divided into lymphocytic, granulocytic, monocytic, plasma cell and megakaryocytic leukemia. 2. Among them, acute granulocytic leukemia type m2a belongs to one kind of acute granulocytic leukemia type m2. Acute granulocytic leukemia m2a type is mainly characterized by: obvious proliferation of the granulocyte system, can be seen Auer vesicles; erythroid, megakaryocyte system proliferation is inhibited; 30% to 90% of the progranulocytes, monocytes <20%, early juvenile granulocytes below the stage >10%. 3. acute granulocytic leukemia m2a type with other acute leukemia, progress faster, need to carry out active comprehensive treatment and care: strengthen nursing patients should be bed rest, give nutritious letters, pay attention to hygiene. Strengthen the anti-infection and symptomatic treatment, such as severe anemia can be transfused, bleeding is heavy can be transfused and use hemostatic drugs. Commonly used drugs such as methotrexate, cytarabine, cyclophosphamide, vincristine and other chemical drugs chemotherapy, can also be used jointly. Bone marrow transplantation is also available. It is recommended that patients with this disease go to regular hospitals to receive professional diagnosis and treatment in a timely manner, and should not take medication on their own to avoid delaying their condition.